Multistep tumorigenesis of multiple myeloma: Its molecular delineationIIDA, Shinsuke; UEDA, Ryuzo.International journal of hematology. 2003, Vol 77, Num 3, pp 207-212, issn 0925-5710, 6 p.Article

Antibody therapy for Adult T-cell leukemia―lymphoma : Adult T-cell Leukemia: from Discovery to Recent ProgressISHIDA, Takashi; UEDA, Ryuzo.International journal of hematology. 2011, Vol 94, Num 5, pp 443-452, issn 0925-5710, 10 p.Article

Immunopathogenesis of lymphoma: Focus on CCR4ISHIDA, Takashi; UEDA, Ryuzo.Cancer science. 2011, Vol 102, Num 1, pp 44-50, issn 1347-9032, 7 p.Article

Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphomaKUSUMOTO, Shigeru; TANAKA, Yasuhito; MIZOKAMI, Masashi et al.International journal of hematology. 2009, Vol 90, Num 1, pp 13-23, issn 0925-5710, 11 p.Article

Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjectsDOHI, Yasuaki; TAKASE, Hiroyuki; SATO, Koichi et al.International journal of cardiology. 2007, Vol 115, Num 1, pp 63-66, issn 0167-5273, 4 p.Article

Lack of Ku80 alteration in multiple myelomaKATO, Miyuki; IIDA, Shinsuke; KOMATSU, Hirokazu et al.Japanese journal of cancer research. 2002, Vol 93, Num 4, pp 359-362, issn 0910-5050Article

Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoidSANDA, Takaomi; IIDA, Shinsuke; KAYUKAWA, Satoshi et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 115-120, issn 0390-6078, 6 p.Article

A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2bKATO, Hideaki; NAKAMURA, Makoto; NAKAMURA, Atsushi et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 1, pp 121-122, issn 0954-691X, 2 p.Article

The 14th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium Challenges in cancer metastasis, 11-12 September 1998, Nagoya, JapanSAITO, Hidehiko; OGAWA, Makoto; UEDA, Ryuzo et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, issn 0344-5704, 103 p., SUPConference Proceedings

Marimastat (BB2516) : Current status of developmentSTEWARD, W. P.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S56-S60, issn 0344-5704, SUPConference Paper

In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectorsCRYSTAL, R. G.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S90-S99, issn 0344-5704, SUPConference Paper

The 18th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, New strategies for novel anticancer drug development, 8-9 November 2002, Nagoya, JapanARIYOSHI, Yutaka; OGAWA, Makoto; SAITO, Hidehiko et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, issn 0344-5704, 101 p., SUP1Conference Proceedings

Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapiesFRIEDMAN, M. A.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S100-S103, issn 0344-5704, SUPConference Paper

Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domainKIYOI, Hitoshi; OHNO, Ryuzo; UEDA, Ryuzo et al.Oncogene (Basingstoke). 2002, Vol 21, Num 16, pp 2555-2563, issn 0950-9232Article

Critical determinants of cancer metastasis : rationale for therapyFIDLER, I. J.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S3-S10, issn 0344-5704, SUPConference Paper

Successful management of microscopic residual disease in large bowel cancerSUGARBAKER, P. H.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S15-S25, issn 0344-5704, SUPConference Paper

SCID-hu mice for the study of human cancer metastasisNAMIKAWA, R; SHTIVELMAN, E.Cancer chemotherapy and pharmacology. 1999, Vol 43, pp S37-S41, issn 0344-5704, SUPConference Paper

Significance of thymidylate synthase for resistance to pemetrexed in lung cancerOZASA, Hiroaki; OGURI, Tetsuya; UEMURA, Takehiro et al.Cancer science. 2010, Vol 101, Num 1, pp 161-166, issn 1347-9032, 6 p.Article

Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockersTAKASE, Hiroyuki; NAKAZAWA, Ai; YAMASHITA, Sumiyo et al.Metabolism, clinical and experimental. 2007, Vol 56, Num 4, pp 559-564, issn 0026-0495, 6 p.Article

Defining clinically relevant molecular subsets of lung cancerPAO, William.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s11-s15, SUP1Conference Paper

Clinical development of EGFR-tyrosine kinase inhibitors in JapanNAKAGAWA, Kazuhiko.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s33-s37, SUP1Conference Paper

Efficacy of docetaxel as a second-line chemotherapy for thymic carcinomaOGURI, Tetsuya; ACHIWA, Hiroyuki; KATO, Daisuke et al.Chemotherapy (Basel). 2004, Vol 50, Num 6, pp 279-282, issn 0009-3157, 4 p.Article

Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemiaMINAMI, Yosuke; YAMAMOTO, Kazuhito; KIYOI, Hitoshi et al.Blood. 2003, Vol 102, Num 8, pp 2969-2975, issn 0006-4971, 7 p.Article

Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in JapanTOBINAI, Kensei.Cancer chemotherapy and pharmacology. 2003, Vol 52, pp S90-S96, issn 0344-5704, SUP1Conference Paper

Structural development of synthetic retinoids and thalidomide-related moleculesHASHIMOTO, Yuichi.Cancer chemotherapy and pharmacology. 2003, Vol 52, pp S16-S23, issn 0344-5704, SUP1Conference Paper